In February 2012, the organization warned 19 medical practices that they have received a counterfeit version of the cancer drug Avastin. On three more occasions the FDA issued alike warnings about counterfeit Avastin and Altuzan, another brand name for the similar drug. The alerts were also primarily under attack at drugs distributed by Canada Drugs.
A request for remark from the drug distributor was not instantly returned. Drug shortages increased the economic incentives for some pharmacies to offer counterfeit or criminally imported drugs. The drugs topic to warnings has all been inject able treatments typically dispersed through medical practices and not straight to patients.
A request for remark from the drug distributor was not instantly returned. Drug shortages increased the economic incentives for some pharmacies to offer counterfeit or criminally imported drugs. The drugs topic to warnings has all been inject able treatments typically dispersed through medical practices and not straight to patients.
No comments:
Post a Comment